{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:28:06Z","timestamp":1792931286634,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03374-x","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:14:34Z","timestamp":1775578474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Harnessing Hybrid Niosomes for Improved Oral Bioavailability of an Anticoagulant: Design, Optimization and In-Vivo Pharmacokinetics and Pharmacodynamics Evaluations"],"prefix":"10.1208","volume":"27","author":[{"given":"Remonda Raafat","family":"Ragheb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodayana","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-1650","authenticated-orcid":false,"given":"Kareem","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-9502","authenticated-orcid":false,"given":"Sadek","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-7133","authenticated-orcid":false,"given":"Ahmed M.","family":"Fatouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"5","key":"3374_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/1358863X231154756","volume":"28","author":"C Frank","year":"2023","unstructured":"Frank C, Ratchford EV, Moll S. Vascular disease patient information page: a guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism. Vasc Med. 2023;28(5):481\u20136. https:\/\/doi.org\/10.1177\/1358863X231154756.","journal-title":"Vasc Med"},{"key":"3374_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2025.109516","volume":"256","author":"J Hugueny","year":"2025","unstructured":"Hugueny J, de Ricolfis A, Johnson N, Chabbert-Buffet N, Cristofari S. Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: a literature review. Thromb Res. 2025;256:109516. https:\/\/doi.org\/10.1016\/j.thromres.2025.109516.","journal-title":"Thromb Res"},{"key":"3374_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jen.2025.08.009","author":"M Scannell","year":"2025","unstructured":"Scannell M, Mackey S, Boudrow C, Sullivan D, Narsule CK. Enhancing patient care: venous thromboembolism prophylaxis in the emergency department. J Emerg Nurs. 2025. https:\/\/doi.org\/10.1016\/j.jen.2025.08.009.","journal-title":"J Emerg Nurs"},{"issue":"22","key":"3374_CR4","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","volume":"2","author":"DM Witt","year":"2018","unstructured":"Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257\u201391. https:\/\/doi.org\/10.1182\/bloodadvances.2018024893.","journal-title":"Blood Adv"},{"issue":"5","key":"3374_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/TA.0000000000002830","volume":"89","author":"EJ Ley","year":"2020","unstructured":"Ley EJ, Brown CVR, Moore EE, Sava JA, Peck K, Ciesla DJ, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89(5):971\u201381. https:\/\/doi.org\/10.1097\/TA.0000000000002830.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"3374_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/milmed\/usy072","volume":"183","author":"DJ Grabo","year":"2018","unstructured":"Grabo DJ, Seery JM, Bradley M, Zakaluzny S, Kearns MJ, Fernandez N, et al. Prevention of deep venous thromboembolism. Mil Med. 2018;183(2):133\u20136. https:\/\/doi.org\/10.1093\/milmed\/usy072.","journal-title":"Mil Med"},{"issue":"12","key":"3374_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/heartjnl-2014-307019","volume":"102","author":"AD Blann","year":"2016","unstructured":"Blann AD, Lip GY. Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. Heart. 2016;102(12):975\u201383. https:\/\/doi.org\/10.1136\/heartjnl-2014-307019.","journal-title":"Heart"},{"issue":"5","key":"3374_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/ejh.12610","volume":"95","author":"A Gomez-Outes","year":"2015","unstructured":"Gomez-Outes A, Suarez-Gea ML, Lecumberri R, Terleira-Fernandez AI, Vargas-Castrillon E. Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives. Eur J Haematol. 2015;95(5):389\u2013404. https:\/\/doi.org\/10.1111\/ejh.12610.","journal-title":"Eur J Haematol"},{"key":"3374_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118732","volume":"193","author":"E Gonz\u00e1lez-Iglesias","year":"2025","unstructured":"Gonz\u00e1lez-Iglesias E, Ochoa D, Abbes H, Villapalos-Garc\u00eda G, Rom\u00e1n M, Luquero S, et al. Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter. Biomed Pharmacother. 2025;193:118732. https:\/\/doi.org\/10.1016\/j.biopha.2025.118732.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"3374_CR10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","volume":"58","author":"W Byon","year":"2019","unstructured":"Byon W, Garonzik S, Boyd RA, Frost CE. Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2019;58(10):1265\u201379. https:\/\/doi.org\/10.1007\/s40262-019-00775-z.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"3374_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/1389200218666170424151551","volume":"18","author":"P Kubisz","year":"2017","unstructured":"Kubisz P, Stanciakova L, Dobrotova M, Samos M, Mokan M, Stasko J. Apixaban - metabolism, pharmacologic properties and drug interactions. Curr Drug Metab. 2017;18(7):609\u201321. https:\/\/doi.org\/10.2174\/1389200218666170424151551.","journal-title":"Curr Drug Metab"},{"key":"3374_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010080","author":"MF Zaky","year":"2022","unstructured":"Zaky MF, Megahed MA, Hammady TM, Gad S, Ghorab MM, El-Say KM. Tailoring apixaban in nanostructured lipid carrier enhancing its oral bioavailability and anticoagulant activity. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics15010080.","journal-title":"Pharmaceutics"},{"issue":"17","key":"3374_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2020.17272","volume":"324","author":"R Chopard","year":"2020","unstructured":"Chopard R, Albertsen IE, Piazza G. Diagnosis and treatment of lower extremity venous thromboembolism: a review. JAMA. 2020;324(17):1765\u201376. https:\/\/doi.org\/10.1001\/jama.2020.17272.","journal-title":"JAMA"},{"issue":"8","key":"3374_CR14","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03233-1","volume":"26","author":"Y Elmahboub","year":"2025","unstructured":"Elmahboub Y, Albash R, Ahmed S, Salah S. The road to precision nanomedicine: an insight on drug repurposing and advances in nanoformulations for treatment of cancer. AAPS PharmSciTech. 2025;26(8): 237. https:\/\/doi.org\/10.1208\/s12249-025-03233-1.","journal-title":"AAPS PharmSciTech"},{"key":"3374_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105728","volume":"96","author":"NF Younes","year":"2024","unstructured":"Younes NF, Sayed S, Hassan M, Ahmed S. Engineered lecithin-based proniosomes for enhanced trans-tympanic permeation: in vitro, microbiological, ex vivo and in vivo evaluation. J Drug Deliv Sci Technol. 2024;96:105728. https:\/\/doi.org\/10.1016\/j.jddst.2024.105728.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3374_CR16","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02575-y","volume":"24","author":"MM Farag","year":"2023","unstructured":"Farag MM, El-Sebaie W, Basalious EB, El-Gazayerly ON. Darifenacin self-assembled liquid crystal cubic nanoparticles: a sustained release approach for an overnight control of overactive bladder. AAPS PharmSciTech. 2023;24(5): 120. https:\/\/doi.org\/10.1208\/s12249-023-02575-y.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"3374_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/00914037.2024.2335169","volume":"74","author":"S Faheem","year":"2025","unstructured":"Faheem S, Hameed H, Paiva-Santos AC, Zaman M, Sarwar HS, Majeed I. Niosome-based gels: a smart nano-carrier for effective and advanced transdermal drug delivery. Int J Polym Mater Polym Biomater. 2025;74(4):317\u201335. https:\/\/doi.org\/10.1080\/00914037.2024.2335169.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"7","key":"3374_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070910","volume":"16","author":"K Patil","year":"2024","unstructured":"Patil K, Gujarathi N, Sharma C, Ojha S, Goyal S, Agrawal Y. Quality-by-design-driven nanostructured lipid scaffold of Apixaban: optimization, characterization, and pharmacokinetic evaluation. Pharmaceutics. 2024;16(7): 910. https:\/\/doi.org\/10.3390\/pharmaceutics16070910.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3374_CR19","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02628-2","volume":"24","author":"SE Ramadan","year":"2023","unstructured":"Ramadan SE, El-Gizawy SA, Osman MA, Arafa MF. Application of design of experiment in the optimization of apixaban-loaded solid lipid nanoparticles: in vitro and in vivo evaluation. AAPS PharmSciTech. 2023;24(6): 167. https:\/\/doi.org\/10.1208\/s12249-023-02628-2.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3374_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40005-024-00712-8","volume":"55","author":"F Din","year":"2025","unstructured":"Din F, Lee HI, Kim JS, Woo MR, Cheon S, Park S, et al. Physicochemical characterization and in vivo assessment of novel apixaban-loaded polymeric nano-aggregates. J Pharm Investig. 2025;55(5):707\u201319. https:\/\/doi.org\/10.1007\/s40005-024-00712-8.","journal-title":"J Pharm Investig"},{"issue":"4","key":"3374_CR21","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-02020-y","volume":"22","author":"AA El-Shenawy","year":"2021","unstructured":"El-Shenawy AA, Mahmoud RA, Mahmoud EA, Mohamed MS. Intranasal in situ gel of Apixaban-loaded nanoethosomes: preparation, optimization, and in vivo evaluation. AAPS PharmSciTech. 2021;22(4): 147. https:\/\/doi.org\/10.1208\/s12249-021-02020-y.","journal-title":"AAPS PharmSciTech"},{"key":"3374_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","volume":"51","author":"VR Salvi","year":"2019","unstructured":"Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier. J Drug Deliv Sci Technol. 2019;51:255\u201367. https:\/\/doi.org\/10.1016\/j.jddst.2019.02.017.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/polym17070833","author":"L Eltaib","year":"2025","unstructured":"Eltaib L. Polymeric nanoparticles in targeted drug delivery: unveiling the impact of polymer characterization and fabrication. Polymers. 2025. https:\/\/doi.org\/10.3390\/polym17070833.","journal-title":"Polymers"},{"issue":"1","key":"3374_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-025-00232-w","volume":"2","author":"P Patra","year":"2025","unstructured":"Patra P. Cutting-edge advances in transethosomes and nanoethosomes for transdermal drug delivery. Discover Chemistry. 2025;2(1):148. https:\/\/doi.org\/10.1007\/s44371-025-00232-w.","journal-title":"Discover Chemistry"},{"key":"3374_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100430","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Saher O, ElBishbishy RM, Ibrahim MM. Revolutionary hyaluronic acid-modified edge-activated spanlastics as a novel approach to boost hepatoprotective activity of Curcumin: optimization, biochemical analysis and in-vivo assessment. Int J Pharm: X. 2025. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100430.","journal-title":"Int J Pharm: X"},{"key":"3374_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100425","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Attia H, Saher O. Novel hybrid tri-polymer hyalurosomes: unlocking next-generation trans-tympanic therapeutics through multi-scale evaluations. International Journal of Pharmaceutics: X. 2025. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100425.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"5","key":"3374_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/02652048.2025.2500542","volume":"42","author":"MM Farag","year":"2025","unstructured":"Farag MM, Abdelmalak NS, El Menshawe SF, Omara AS, Hamad DS. Repurposing linagliptin-loaded novasomes as a neuroprotectant for Alzheimer\u2019s disease: in-vitro characterisation, statistical optimisation and ex-vivo permeation study. J Microencapsul. 2025;42(5):531\u201345. https:\/\/doi.org\/10.1080\/02652048.2025.2500542.","journal-title":"J Microencapsul"},{"key":"3374_CR28","doi-asserted-by":"publisher","unstructured":"Ahmed S, Attallah KM, Sayyed ME.\u00a0Engineered Novel Brijaluronic Terpesomes for Brain-Targeted Quercetin Delivery:Optimization, Ex Vivo and Radiokinetics. AAPS PharmSciTech; 2026. https:\/\/doi.org\/10.1208\/s12249-026-03366-x.","DOI":"10.1208\/s12249-026-03366-x"},{"key":"3374_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01522-z","author":"S Ahmed","year":"2024","unstructured":"Ahmed S, Aziz DE, Sadek MA, Tawfik MA. Capped flexosomes for prominent anti-inflammatory activity: development, optimization, and ex vivo and in vivo assessments. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01522-z.","journal-title":"Drug Deliv Transl Res"},{"key":"3374_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04659-x","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Fayez A, Attia H, El-Setouhy DA. Terpene-augmented novasomal carriers for trans-tympanic drug delivery: a comprehensive optimization and in vivo evaluation. Naunyn Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-04659-x.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3374_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1560585","volume":"16","author":"MA El Hassab","year":"2025","unstructured":"El Hassab MA, Ibrahim MH, Abdel Mageed SS, Mahmoud AMA, Othman Ahmed ZS, Mosallam S, et al. Formulation of zein nanoparticles for augmenting the anti-inflammatory activity of dexketoprofen. Front Pharmacol. 2025;16:1560585. https:\/\/doi.org\/10.3389\/fphar.2025.1560585.","journal-title":"Front Pharmacol"},{"key":"3374_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107493","volume":"114","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Ibrahim MM, Balkhi B, Attia H, Aziz DE. From bench to biology: unraveling the efficiency of novel brijosomes for trans-tympanic drug delivery. J Drug Deliv Sci Technol. 2025;114:107493. https:\/\/doi.org\/10.1016\/j.jddst.2025.107493.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3374_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101912","volume":"32","author":"R El Hosary","year":"2024","unstructured":"El Hosary R, Teaima MH, El-Nabarawi M, Yousry Y, Eltahan M, Bakr A, et al. Topical delivery of extracted curcumin as curcumin loaded spanlastics anti-aging gel: optimization using experimental design and ex-vivo evaluation. Saudi Pharm J. 2024;32(1):101912. https:\/\/doi.org\/10.1016\/j.jsps.2023.101912.","journal-title":"Saudi Pharm J"},{"key":"3374_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213823","volume":"159","author":"L Bender","year":"2024","unstructured":"Bender L, Ayoub AM, Schulze J, Amin MU, Librizzi D, Engelhardt KH, et al. Evaluating the photodynamic efficacy of nebulized curcumin-loaded liposomes prepared by thin-film hydration and dual centrifugation: In vitro and in ovo studies. Biomaterials Advances. 2024;159:213823. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213823.","journal-title":"Biomaterials Advances"},{"key":"3374_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105912","volume":"98","author":"MA Abdelbari","year":"2024","unstructured":"Abdelbari MA, El-Gazar AA, Abdelbary AA, Elshafeey AH, Mosallam S. Investigating the potential of novasomes in improving the trans-tympanic delivery of niflumic acid for effective treatment of acute otitis media. J Drug Deliv Sci Technol. 2024;98:105912. https:\/\/doi.org\/10.1016\/j.jddst.2024.105912.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3374_CR36","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03250-0","volume":"27","author":"MA Tawfik","year":"2025","unstructured":"Tawfik MA, Ahmed S, El-Dahmy RM, Aziz DE. Oleic acid enriched Leciplexes as novel mucoadhesive cationic nanocarriers of Agomelatine for Glaucoma Treatment. AAPS PharmSciTech. 2025;27(1): 4. https:\/\/doi.org\/10.1208\/s12249-025-03250-0.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3374_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-02105-z","volume":"15","author":"MT Teama","year":"2025","unstructured":"Teama MT, Abdelmalak NS, Naguib MJ, Ahmed S. Polymeric micelles for pulmonary drug delivery: a comprehensive review. BioNanoScience. 2025;15(3):504. https:\/\/doi.org\/10.1007\/s12668-025-02105-z.","journal-title":"BioNanoScience"},{"key":"3374_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107192","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Mehana D, Attia H, El-Ashmoony MM. Engineered terconazole-loaded flexogel for targeted vaginal delivery: in-depth analysis using in-vitro, microbiological, ex-vivo and in-vivo methodologies. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.107192.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100355","volume":"10","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Saher O, Attia H, Fahmy AM, Adel IM. Development and characterization of fenticonazole nitrate-loaded cubogel for the management of vaginal candidiasis. International Journal of Pharmaceutics: X. 2025;10: 100355. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100355.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3374_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107061","volume":"208","author":"R Albash","year":"2025","unstructured":"Albash R, Fahmy AM, Shamsel-Din HA, Ibrahim AB, Bogari HA, Malatani RT, et al. Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: optimization and biodistribution study by radiobiological evaluation. Eur J Pharm Sci. 2025;208:107061. https:\/\/doi.org\/10.1016\/j.ejps.2025.107061.","journal-title":"Eur J Pharm Sci"},{"key":"3374_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106875","volume":"201","author":"R Albash","year":"2024","unstructured":"Albash R, Abdelbari MA, Elbesh RM, Khaleel EF, Badi RM, Eldehna WM, et al. <article-title update=\"added\">Sonophoresis mediated diffusion of caffeine loaded Transcutol\u00ae enriched cerosomes for topical management of cellulite. Eur J Pharm Sci. 2024;201:106875. https:\/\/doi.org\/10.1016\/j.ejps.2024.106875.","journal-title":"Eur J Pharm Sci"},{"key":"3374_CR42","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-026-03342-5","author":"AM Fahmy","year":"2026","unstructured":"Fahmy AM, Saher O, Attia H, Farag MM, Ahmed S. Harnessing Novel Tetra-Synergistic Bilosomes for Effective Otomycosis Management: Integrated In-Vitro. Microbiological and In-Vivo Studies AAPS PharmSciTech. 2026. https:\/\/doi.org\/10.1208\/s12249-026-03342-5.","journal-title":"Microbiological and In-Vivo Studies AAPS PharmSciTech"},{"key":"3374_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106368","volume":"102","author":"A Hussein","year":"2024","unstructured":"Hussein A, El-Kayal M, Shamma RN, Awad HH, Younes NF. Optimizing nutraceutical-loaded trehalosomes in-situ gel for diabetic cataract management: comprehensive in vitro and in vivo evaluations. J Drug Deliv Sci Technol. 2024;102:106368. https:\/\/doi.org\/10.1016\/j.jddst.2024.106368.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1767624","author":"AE Eldeeb","year":"2026","unstructured":"Eldeeb AE, Aziz DE, Hassan M, Saher O, Ahmed S. Ketoprofen-loaded quatsomes as a smart repurposed antifungal therapy for vaginal infections: formulation, characterization, and microbiological evaluation. Front Pharmacol. 2026. https:\/\/doi.org\/10.3389\/fphar.2026.1767624.","journal-title":"Front Pharmacol"},{"key":"3374_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106876","volume":"108","author":"AM Fahmy","year":"2025","unstructured":"Fahmy AM, Balkhi B, Sadek MA, ElBishbishy RM, Ahmed S. PEGylated terpesomes of curcumin for prominent hepatoprotective activity: fabrication, optimization, biochemical analysis and in vivo evaluation. J Drug Deliv Sci Technol. 2025;108:106876. https:\/\/doi.org\/10.1016\/j.jddst.2025.106876.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107477","volume":"114","author":"AA Nemr","year":"2025","unstructured":"Nemr AA, Farag MM, Hegazy D, Attia H, Abdelhakeem E. Visionary nanoboost: revolutionizing ocular treatment with positively charged leciplex for enhanced Fenticonazole nitrate ocular delivery. J Drug Deliv Sci Technol. 2025;114:107477. https:\/\/doi.org\/10.1016\/j.jddst.2025.107477.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100333","volume":"9","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Farag MM, Attia H, Balkhi B, Adel IM, Nemr AA. Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: in-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation. International Journal of Pharmaceutics: X. 2025;9: 100333. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100333.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3374_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100322","volume":"9","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Farag MM, Attia H, Balkhi B, Adel IM, Nemr AA. Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: a comprehensive investigation from laboratory characterization to microbiological evaluation. International Journal of Pharmaceutics: X. 2025;9: 100322. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100322.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3374_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107680","volume":"115","author":"MM El-Naggar","year":"2026","unstructured":"El-Naggar MM, El-Nabarawi MA, Hassan M, Hamed MIA, Elrashedy AA, Teaima MH, et al. PEG-decorated emulsomal gel loaded levocetirizine dihydrochloride as repurposed cure for effective management of methicillin-resistant Staphylococcus aureus (MRSA) vaginal infection: D-optimal design optimization, ex-vivo, in-silico, and in-vivo studies. J Drug Deliv Sci Technol. 2026;115:107680. https:\/\/doi.org\/10.1016\/j.jddst.2025.107680.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-024-00666-x","author":"HA Elgendy","year":"2024","unstructured":"Elgendy HA, Makky AMA, Elakkad YE, Awad HH, Hassab MAE, Younes NF. Atorvastatin loaded lecithin-coated zein nanoparticles based thermogel for the intra-articular management of osteoarthritis: in-silico, in-vitro, and in-vivo studies. J Pharm Investig. 2024. https:\/\/doi.org\/10.1007\/s40005-024-00666-x.","journal-title":"J Pharm Investig"},{"key":"3374_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100295","volume":"8","author":"S Ahmed","year":"2024","unstructured":"Ahmed S, Attia H, Saher O, Fahmy AM. Augmented glycerosomes as a promising approach against fungal ear infection: optimization and microbiological, ex vivo and in vivo assessments. International Journal of Pharmaceutics: X. 2024;8:100295. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100295.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"5","key":"3374_CR52","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02280-2","volume":"23","author":"MM Farag","year":"2022","unstructured":"Farag MM, Louis MM, Badawy AA, Nessem DI, Elmalak NSA. Drotaverine hydrochloride superporous hydrogel hybrid system: a gastroretentive approach for sustained drug delivery and enhanced viscoelasticity. AAPS PharmSciTech. 2022;23(5):124. https:\/\/doi.org\/10.1208\/s12249-022-02280-2.","journal-title":"AAPS PharmSciTech"},{"key":"3374_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12080732","author":"J Weng","year":"2020","unstructured":"Weng J, Tong HHY, Chow SF. In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12080732.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3374_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2024.2382974","volume":"35","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Farag MM, Sadek MA, Aziz DE. Transdermal application of diacerin loaded-terpene enriched invasomes: an approach to augment anti-edema and nociception inhibition activity. J Liposome Res. 2025;35(1):1\u201314. https:\/\/doi.org\/10.1080\/08982104.2024.2382974.","journal-title":"J Liposome Res"},{"key":"3374_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1746918","author":"S Ahmed","year":"2026","unstructured":"Ahmed S, Saher O, Attia H, Fahmy AM, Adel IM. Innovative dual-functional hybrid cationic PEGylated proniosomes as a smart nano-platform for boosted vaginal delivery: multi-level in-vitro, ex-vivo, microbiological, and in-vivo studies. Front Pharmacol. 2026. https:\/\/doi.org\/10.3389\/fphar.2025.1746918.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3374_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.207","volume":"4","author":"W Ankrom","year":"2016","unstructured":"Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, et al. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacology Research & Perspectives. 2016;4(1):e00207. https:\/\/doi.org\/10.1002\/prp2.207.","journal-title":"Pharmacology Research & Perspectives"},{"issue":"5","key":"3374_CR57","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10787-020-00693-8","volume":"28","author":"O El-Ghafar","year":"2020","unstructured":"El-Ghafar O, Helal GK, Abo-Youssef AM. Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2\/STAT3 and MAPK phosphorylation pathways. Inflammopharmacology. 2020;28(5):1253\u201367. https:\/\/doi.org\/10.1007\/s10787-020-00693-8.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"3374_CR58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00210-022-02312-5","volume":"396","author":"R Ono","year":"2023","unstructured":"Ono R, Nishimura K, Takahashi H, Hori Y, Fukushima K, Kobayashi Y. Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(2):323\u201336. https:\/\/doi.org\/10.1007\/s00210-022-02312-5.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3374_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.164321","volume":"518","author":"X-A Liu","year":"2025","unstructured":"Liu X-A, Hussain Y, Wang J, Xia P, Huang X-X, Huo M-W, et al. Engineering Long-Acting apixaban loaded PLGA microspheres for the treatment of stroke caused by atrial fibrillation. Chem Eng J. 2025;518:164321. https:\/\/doi.org\/10.1016\/j.cej.2025.164321.","journal-title":"Chem Eng J"},{"issue":"11","key":"3374_CR60","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1111\/bcp.15862","volume":"89","author":"OA Kotila","year":"2023","unstructured":"Kotila OA, Ajayi DT, Masimirembwa C, Thelingwani R, Odetunde A, Falusi AG, et al. Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: a pilot study. Br J Clin Pharmacol. 2023;89(11):3454\u20139. https:\/\/doi.org\/10.1111\/bcp.15862.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3374_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40268-014-0066-4","volume":"14","author":"M Mayer","year":"2014","unstructured":"Mayer M, Nudurupati S, Peng X, Marcinak J. Evaluation of the pharmacokinetics and safety of a single oral dose of fasiglifam in subjects with normal or varying degrees of impaired renal function. Drugs RD. 2014;14(4):273\u201382. https:\/\/doi.org\/10.1007\/s40268-014-0066-4.","journal-title":"Drugs RD"},{"key":"3374_CR62","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejps.2018.01.044","volume":"115","author":"BA Habib","year":"2018","unstructured":"Habib BA, Sayed S, Elsayed GM. Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example. Eur J Pharm Sci. 2018;115:352\u201361. https:\/\/doi.org\/10.1016\/j.ejps.2018.01.044.","journal-title":"Eur J Pharm Sci"},{"key":"3374_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100160","volume":"5","author":"E Taha","year":"2023","unstructured":"Taha E, Nour SA, Mamdouh W, Selim AA, Swidan MM, Ibrahim AB, et al. Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone. Int J Pharm X. 2023;5:100160. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100160.","journal-title":"Int J Pharm X"},{"key":"3374_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100357","volume":"10","author":"NF Younes","year":"2025","unstructured":"Younes NF, Latif R, Badawi A, Hegazy K. Optimized buccoadhesive repaglinide-loaded cubogel: In-vitro characterization and in-vivo hypoglycemic activity in a streptozotocin-induced diabetic rat model. International Journal of Pharmaceutics: X. 2025;10: 100357. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100357.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"1\u20132","key":"3374_CR65","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","volume":"513","author":"AA Abdelbary","year":"2016","unstructured":"Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm. 2016;513(1\u20132):688\u201396. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.006.","journal-title":"Int J Pharm"},{"issue":"1","key":"3374_CR66","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","volume":"24","author":"GA Abdelbary","year":"2017","unstructured":"Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309\u201319. https:\/\/doi.org\/10.1080\/10717544.2016.1247928.","journal-title":"Drug Deliv"},{"key":"3374_CR67","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.2147\/IJN.S319348","volume":"16","author":"MA Abdelbari","year":"2021","unstructured":"Abdelbari MA, El-Mancy SS, Elshafeey AH, Abdelbary AA. Implementing spanlastics for improving the ocular delivery of clotrimazole: In vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. Int J Nanomedicine. 2021;16:6249\u201361. https:\/\/doi.org\/10.2147\/IJN.S319348.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3374_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejpb.2010.10.011","volume":"77","author":"HM El-Laithy","year":"2011","unstructured":"El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77(1):43\u201355. https:\/\/doi.org\/10.1016\/j.ejpb.2010.10.011.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3374_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/10717544.2019.1609622","volume":"26","author":"A Emad Eldeeb","year":"2019","unstructured":"Emad Eldeeb A, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26(1):509\u201321. https:\/\/doi.org\/10.1080\/10717544.2019.1609622.","journal-title":"Drug Deliv"},{"key":"3374_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/IJN.S287383","volume":"16","author":"S Mosallam","year":"2021","unstructured":"Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomedicine. 2021;16:119\u201332. https:\/\/doi.org\/10.2147\/IJN.S287383.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3374_CR71","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s12247-023-09711-y","volume":"18","author":"MM Younis","year":"2023","unstructured":"Younis MM, Fadel N-F, Darwish AB, Mohsen AM. Nanospanlastics as a novel approach for improving the oral delivery of resveratrol in lipopolysaccharide-induced endotoxicity in mice. J Pharm Innov. 2023;18(3):1264\u201378. https:\/\/doi.org\/10.1007\/s12247-023-09711-y.","journal-title":"J Pharm Innov"},{"key":"3374_CR72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jddst.2019.04.036","volume":"52","author":"A Emad Eldeeb","year":"2019","unstructured":"Emad Eldeeb A, Salah S, Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 2019;52:236\u201347. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.036.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3374_CR73","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/IJN.S345430","volume":"17","author":"RA Shalaby","year":"2022","unstructured":"Shalaby RA, El-Gazayerly O, Abdallah M. Cubosomal betamethasone-salicylic acid nano drug delivery system for enhanced management of scalp psoriasis. Int J Nanomedicine. 2022;17:1659\u201377. https:\/\/doi.org\/10.2147\/IJN.S345430.","journal-title":"Int J Nanomedicine"},{"key":"3374_CR74","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/IJN.S274290","volume":"16","author":"R Albash","year":"2021","unstructured":"Albash R, Al-Mahallawi AM, Hassan M, Alaa-Eldin AA. Development and optimization of terpene-enriched vesicles (Terpesomes) for effective ocular delivery of fenticonazole nitrate: in vitro characterization and in vivo assessment. Int J Nanomedicine. 2021;16:609\u201321. https:\/\/doi.org\/10.2147\/IJN.S274290.","journal-title":"Int J Nanomedicine"},{"key":"3374_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124892","volume":"667","author":"AM Helal","year":"2024","unstructured":"Helal AM, Yossef MM, Seif IK, Abd El-Salam M, El Demellawy MA, Abdulmalek SA, et al. Nanostructured biloalbuminosomes loaded with berberine and berberrubine for alleviating heavy metal-induced male infertility in rats. Int J Pharm. 2024;667:124892. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124892.","journal-title":"Int J Pharm"},{"key":"3374_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104957","volume":"88","author":"MM El Taweel","year":"2023","unstructured":"El Taweel MM, Tawfik MA, Soliman K, Khattab MS, Farag MM. Tailoring of topically applied curcumin loaded pro-novasomes for skin cancer treatment: in-vitro characterization, statistical optimization and histopathological assessment of subcutaneous Ehrlich carcinoma mice model. J Drug Deliv Sci Technol. 2023;88:104957. https:\/\/doi.org\/10.1016\/j.jddst.2023.104957.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3374_CR77","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2179129","volume":"30","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration. Drug Deliv. 2023;30(1): 2179129. https:\/\/doi.org\/10.1080\/10717544.2023.2179129.","journal-title":"Drug Deliv"},{"key":"3374_CR78","doi-asserted-by":"crossref","unstructured":"Ahmed S, Mehana D, Attia H, El-Ashmoony MM. Terpene-Enhanced Olaminogel for Superior Vaginal Permeation: Robust Assessment through In-Vitro, Microbiological, Ex-Vivo and In-Vivo Evaluations. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025.","DOI":"10.1007\/s00210-025-04838-w"},{"key":"3374_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2019.01.037","volume":"559","author":"AA Abdelbary","year":"2019","unstructured":"Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: statistical optimization, trans-tympanic permeation and in vivo evaluation. Int J Pharm. 2019;559:201\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.037.","journal-title":"Int J Pharm"},{"key":"3374_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121214","volume":"609","author":"WH Abd-Elsalam","year":"2021","unstructured":"Abd-Elsalam WH, Ibrahim RR. Span 80\/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections. Int J Pharm. 2021;609: 121214. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121214.","journal-title":"Int J Pharm"},{"issue":"1","key":"3374_CR81","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1080\/10717544.2021.1951895","volume":"28","author":"S Sayed","year":"2021","unstructured":"Sayed S, Elsharkawy FM, Amin MM, Shamsel-Din HA, Ibrahim AB. Brain targeting efficiency of intranasal clozapine-loaded mixed micelles following radio labeling with Technetium-99m. Drug Deliv. 2021;28(1):1524\u201338. https:\/\/doi.org\/10.1080\/10717544.2021.1951895.","journal-title":"Drug Deliv"},{"key":"3374_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104363","volume":"82","author":"MG Sakr","year":"2023","unstructured":"Sakr MG, El-Zahaby SA, Al-Mahallawi AM, Ghorab DM. Fabrication of betaxolol hydrochloride-loaded highly permeable ocular bilosomes (HPOBs) to combat glaucoma: in vitro, ex vivo & in vivo characterizations. J Drug Deliv Sci Technol. 2023;82:104363. https:\/\/doi.org\/10.1016\/j.jddst.2023.104363.","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03374-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:48:58Z","timestamp":1780390138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3374"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03374-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The\n                      in vivo\n                      studies were reviewed and approved by the Research Ethics Committee at the School of Pharmacy, Newgiza University, Egypt (Approval No. PI-0097).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}